Key facts
- This page summarizes David R. Stevens's Form 4 filing for Ampio Pharmaceuticals, Inc..
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 May 2023, 17:26.
David R. Stevens - 11 May 2023 Form 4 Insider Report for Ampio Pharmaceuticals, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 11 May 2023
- Net transaction value
- +$20,775
- SEC form
- 4
- Accepted by SEC
- 12 May 2023, 17:26:03 UTC
- Prior SEC filing
- 03 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- Suzette McNally, Attorney-in-Fact for David R. Stevens
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David R. Stevens filed Form 4 for Ampio Pharmaceuticals, Inc. on 12 May 2023.
Change
- Previous filing in this sequence was filed on 03 Jan 2022.
- Current net transaction value: +$20,775.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMPE
transaction
Common Stock
Purchase
- Transaction value
- $5,500
- Shares
- +25,000
- Change %
- +279%
- Price
- $0.2200
- Shares after
- 33,971
- Date
- 11 May 2023
- Ownership
- Direct
AMPE
transaction
Common Stock
Purchase
- Transaction value
- $5,375
- Shares
- +25,000
- Change %
- +74%
- Price
- $0.2150
- Shares after
- 58,971
- Date
- 11 May 2023
- Ownership
- Direct
AMPE
transaction
Common Stock
Purchase
- Transaction value
- $9,900
- Shares
- +45,000
- Change %
- +76%
- Price
- $0.2200
- Shares after
- 103,971
- Date
- 12 May 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.